The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review
Open accessAbstract
The Coronavirus Disease 2019 (COVID-19) is now a global pandemic with millions affected and millions more at risk for contracting the infection. The COVID-19 virus, SARS-CoV-2, affects multiple organ systems, especially the lungs and heart. Elevation of cardiac biomarkers, particularly high-sensitivity troponin and/or creatine kinase MB, is common in patients with COVID-19 infection. In our review of clinical analyses, we found that in 26 studies including 11,685 patients, the weighted pooled prevalence of acute myocardial injury was 20% (ranged from 5% to 38% depending on the criteria used). The plausible mechanisms of myocardial injury include, 1) hyperinflammation and cytokine storm mediated through pathologic T-cells and monocytes leading to myocarditis, 2) respiratory failure and hypoxemia resulting in damage to cardiac myocytes, 3) down regulation of ACE2 expression and subsequent protective signaling pathways in cardiac myocytes, 4) hypercoagulability and development of coronary microvascular thrombosis, 5) diffuse endothelial injury and ‘endotheliitis’ in several organs including the heart, and, 6) inflammation and/or stress causing coronary plaque rupture or supply-demand mismatch leading to myocardial ischemia/infarction. Cardiac biomarkers can be used to aid in diagnosis as well as risk stratification. In patients with elevated hs-troponin, clinical context is important and myocarditis as well as stress induced cardiomyopathy should be considered in the differential, along with type I and type II myocardial infarction. Irrespective of etiology, patients with acute myocardial injury should be prioritized for treatment. Clinical decisions including interventions should be individualized and carefully tailored after thorough review of risks/benefits. Given the complex interplay of SARS-CoV-2 with the cardiovascular system, further investigation into potential mechanisms is needed to guide effective therapies. Randomized trials are urgently needed to investigate treatment modalities to reduce the incidence and mortality associated with COVID-19 related acute myocardial injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedCardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007621 · Cited by 1,428
RetractedMehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31180-6 · Cited by 1,200
RetractedZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347
Clinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,219
Barendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E., & Vos, T. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2013-203104 · Cited by 2,169
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Inciardi, R. M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., Tomasoni, D., Cani, D. S., Cerini, M., Farina, D., Gavazzi, E., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1096 · Cited by 1,858
COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
Siddiqi, H. K., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.012 · Cited by 1,701
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Phua, J., Weng, L., Ling, L., Egi, M., Lim, C.-M., Divatia, J. V., Shrestha, B. R., Arabi, Y. M., Ng, J., Gomersall, C. D., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30161-2 · Cited by 1,509
Du, R.-H., Liang, L.-R., Yang, C.-Q., Wang, W., Cao, T.-Z., Li, M., Guo, G.-Y., Du, J., Zheng, C.-L., Zhu, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00524-2020 · Cited by 1,452
Remdesivir for the Treatment of Covid-19 — Preliminary Report
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,396
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Han, H., Yang, L., Liu, R., Liu, F., Wu, K.-L., Li, J., Liu, X.-H., & Zhu, C.-L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0188 · Cited by 1,223
Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,156
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Mancia, G., Rea, F., Ludergnani, M., Apolone, G., & Corrao, G. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006923 · Cited by 1,073
Myocardial Localization of Coronavirus in COVID-19 Cardiogenic Shock
Tavazzi, G., Pellegrini, C., Maurelli, M., Belliato, M., Sciutti, F., Bottazzi, A., Sepe, P. A., Resasco, T., Camporotondo, R., Bruno, R., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1828 · Cited by 923
SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M., & Butany, J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02153.x · Cited by 893
ST-Segment Elevation in Patients with Covid-19 — A Case Series
Bangalore, S., Sharma, A., Slotwiner, A., Yatskar, L., Harari, R., Shah, B., Ibrahim, H., Friedman, G. H., Thompson, C., Alviar, C. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009020 · Cited by 844
COVID-19 with Different Severities: A Multicenter Study of Clinical Features
Feng, Y., Ling, Y., Bai, T., Xie, Y., Huang, J., Li, J., Xiong, W., Yang, D., Chen, R., Lu, F., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0445oc · Cited by 838
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
Hu, H., Ma, F., Wei, X., & Fang, Y. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa190 · Cited by 687
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
Chen, J., Liu, D., Liu, L., Liu, P., Xu, Q., Xia, L., Ling, Y., Huang, D. F., Song, S., Zhang, D., et al. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.03.03 · Cited by 664
Meng, J., Xiao, G., Zhang, J., He, X., Ou, M., Bi, J., Yang, R., Di, W., Wang, Z., Li, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746200 · Cited by 619
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality
Bonow, R. O., Fonarow, G. C., O’Gara, P. T., & Yancy, C. W. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1105 · Cited by 594
Self-citationClinical Course and Outcomes of 344 Intensive Care Patients with COVID-19
Wang, Y., Lu, X., Li, Y., Chen, H., Chen, T., Su, N., Huang, F., Zhou, J., Zhang, B., Yan, F., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0736le · Cited by 538
Cao, J., Tu, W.-J., Cheng, W., Yu, L., Liu, Y.-K., Hu, X., & Liu, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa243 · Cited by 495
Shi, S., Qin, M., Cai, Y., Liu, T., Shen, B., Yang, F., Cao, S., Liu, X., Xiang, Y., Zhao, Q., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa408 · Cited by 484
Sala, S., Peretto, G., Gramegna, M., Palmisano, A., Villatore, A., Vignale, D., De Cobelli, F., Tresoldi, M., Cappelletti, A. M., Basso, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa286 · Cited by 481
Deng, Q., Hu, B., Zhang, Y., Wang, H., Zhou, X., Hu, W., Cheng, Y., Yan, J., Ping, H., & Zhou, Q. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.087 · Cited by 454
Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3
Kubasiak, L. A., Hernandez, O. M., Bishopric, N. H., & Webster, K. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202474099 · Cited by 438
Clinical observation and management of COVID-19 patients
Li, T., Lu, H., & Zhang, W. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1741327 · Cited by 427
Shi, Q., Zhang, X., Jiang, F., Zhang, X., Hu, N., Bimu, C., Feng, J., Yan, S., Guan, Y., Xu, D., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0598 · Cited by 417
Mehta, N., Kalra, A., Nowacki, A. S., Anjewierden, S., Han, Z., Bhat, P., Carmona-Rubio, A. E., Jacob, M., Procop, G. W., Harrington, S., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1855 · Cited by 400
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic
Bhatt, A. S., Moscone, A., McElrath, E. E., Varshney, A. S., Claggett, B. L., Bhatt, D. L., Januzzi, J. L., Butler, J., Adler, D. S., Solomon, S. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.038 · Cited by 357
Self-citationCOVID-19-related myocarditis in a 21-year-old female patient
Kim, I.-C., Kim, J. Y., Kim, H. A., & Han, S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa288 · Cited by 344
Xiong, F., Tang, H., Liu, L., Tu, C., Tian, J.-B., Lei, C.-T., Liu, J., Dong, J.-W., Chen, W.-L., Wang, X.-H., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020030354 · Cited by 295
Chen, C., Chen, C., Yan, J. T., Zhou, N., Zhao, J. P., & Wang, D. W. (2020) · PubMed · doi:10.3760/cma.j.cn112148-20200225-00123 · Cited by 283
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers
Bavishi, C., Maddox, T. M., & Messerli, F. H. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1282 · Cited by 250
Self-citationWang, R., Pan, M., Zhang, X., Han, M., Fan, X., Zhao, F., Miao, M., Xu, J., Guan, M., Deng, X., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.070 · Cited by 244
Han, H., Xie, L., Liu, R., Yang, J., Liu, F., Wu, K., Chen, L., Hou, W., Feng, Y., & Zhu, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25809 · Cited by 235
Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study
Yu, Y., Xu, D., Fu, S., Zhang, J., Yang, X., Xu, L., Xu, J., Wu, Y., Huang, C., Ouyang, Y., et al. (2020) · Critical Care · doi:10.1186/s13054-020-02939-x · Cited by 194
Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis
Wei, J.-F., Huang, F.-Y., Xiong, T.-Y., Liu, Q., Chen, H., Wang, H., Huang, H., Luo, Y.-C., Zhou, X., Liu, Z.-Y., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-317007 · Cited by 192
Szerlip, M., Anwaruddin, S., Aronow, H. D., Cohen, M. G., Daniels, M. J., Dehghani, P., Drachman, D. E., Elmariah, S., Feldman, D. N., García, S., et al. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28887 · Cited by 130
Javanian, M., Bayani, M., Shokri, M., Zavareh, M. S. H., Babazadeh, A., Yeganeh, B. S., Mohseni, S., Mehraeen, R., Sepidarkish, M., Bijani, A., et al. (2020) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2020-0013 · Cited by 101
Reperfusion of ST-Segment–Elevation Myocardial Infarction in the COVID-19 Era
Daniels, M. J., Cohen, M. G., Bavry, A. A., & Kumbhani, D. J. (2020) · Circulation · doi:10.1161/circulationaha.120.047122 · Cited by 93
Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan
Tu, W., Cao, J., Yu, L., Hu, X., & Liu, Q. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06023-4 · Cited by 83
Acute Myocardial Injury at Hospital Admission Is Associated With All-Cause Mortality in COVID-19
Ni, W., Yang, X., Liu, J., Bao, J., Li, R., Xu, Y. S., Guo, W., Hu, Y., & Gao, Z. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.007 · Cited by 69
SARS-CoV-2–Induced Immune Dysregulation and Myocardial Injury Risk in China
Li, D., Chen, Y., Jia, Y., Tong, L., Tong, J., Wang, W., Liu, Y., Wan, Z., Cao, Y., & Zeng, R. (2020) · Circulation Research · doi:10.1161/circresaha.120.317070 · Cited by 30
COVID-19: An Unintended Force for Medical Revolution?
Wang, X., & Bhatt, D. L. (2020) · The Journal of invasive cardiology/The journal of invasive cardiology · doi:10.25270/jic/20.3204.e81 · Cited by 28
Self-citation
Cited by
Diagnosis and Treatment of Acute Coronary Syndromes: A Review
Bhatt, D. L., Lopes, R. D., & Harrington, R. A. (2022) · JAMA · doi:10.1001/jama.2022.0358 · Cited by 787
Self-citation[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
Chen, J., Liu, D., Liu, L., Liu, P., Xu, Q., Xia, L., Ling, Y., Huang, D. F., Song, S., Zhang, D., et al. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.03.03 · Cited by 664
Silva Andrade, B., Siqueira, S., de Assis Soares, W. R., de Souza Rangel, F., Santos, N. O., dos Santos Freitas, A., Ribeiro da Silveira, P., Tiwari, S., Alzahrani, K. J., Góes-Neto, A., et al. (2021) · Viruses · doi:10.3390/v13040700 · Cited by 435
Characterization of Myocardial Injury in Patients With COVID-19
Giustino, G., Croft, L. B., Stefanini, G. G., Bragato, R., Silbiger, J. J., Vicenzi, M., Danilov, T., Kukar, N., Shaban, N., Kini, A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.069 · Cited by 409
Chen, C., Chen, C., Yan, J. T., Zhou, N., Zhao, J. P., & Wang, D. W. (2020) · PubMed · doi:10.3760/cma.j.cn112148-20200225-00123 · Cited by 283
Metadata
- Authors
- Bavishi, C., Bonow, R. O., Trivedi, V., Abbott, J. D., Messerli, F. H., & Bhatt, D. L.
- Venue
- Progress in Cardiovascular Diseases
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 63
- Issue
- 5
- Pages
- 682-689
- ISSN
- 0033-0620 (ISSN-L)
- OpenAlex
- W3034144687
- Cited by
- 298
- References
- 60
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.